Bain Capital Life Sciences Investors as of March 31, 2020
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 11 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 33.2 | $197M | 7.3M | 27.00 | |
| Arcutis Biotherapeutics (ARQT) | 20.1 | $119M | 4.0M | 29.80 | |
| Dicerna Pharmaceuticals | 12.7 | $75M | 4.1M | 18.37 | |
| Constellation Pharmceticls I | 11.7 | $69M | 2.2M | 31.43 | |
| Dynavax Technologies (DVAX) | 5.2 | $31M | 8.7M | 3.53 | |
| Replimune Group (REPL) | 4.8 | $28M | 2.8M | 9.97 | |
| Savara (SVRA) | 3.9 | $23M | 5.1M | 4.48 | |
| X4 Pharmaceuticals (XFOR) | 2.8 | $17M | 1.6M | 10.00 | |
| Marinus Pharmaceuticals | 2.0 | $12M | 5.9M | 2.03 | |
| Aptinyx | 2.0 | $12M | 5.6M | 2.16 | |
| Solid Biosciences | 1.6 | $9.3M | 3.9M | 2.39 |
